BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 27135364)

  • 1. Plasma Proteome Profiling to Assess Human Health and Disease.
    Geyer PE; Kulak NA; Pichler G; Holdt LM; Teupser D; Mann M
    Cell Syst; 2016 Mar; 2(3):185-95. PubMed ID: 27135364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
    Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
    J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated proteomic sample preparation with combination of on-line high-abundance protein depletion, denaturation, reduction, desalting and digestion to achieve high throughput plasma proteome quantification.
    Li Y; Yuan H; Dai Z; Zhang W; Zhang X; Zhao B; Liang Z; Zhang L; Zhang Y
    Anal Chim Acta; 2021 Apr; 1154():338343. PubMed ID: 33736814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass Spectrometry-Based Serum Proteomics for Biomarker Discovery and Validation.
    Bhosale SD; Moulder R; Kouvonen P; Lahesmaa R; Goodlett DR
    Methods Mol Biol; 2017; 1619():451-466. PubMed ID: 28674903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Highly Automated Shotgun Proteomic Workflow: Clinical Scale and Robustness for Biomarker Discovery in Blood.
    Dayon L; Núñez Galindo A; Cominetti O; Corthésy J; Kussmann M
    Methods Mol Biol; 2017; 1619():433-449. PubMed ID: 28674902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Quantitative Comparisons of Plasma Proteomes Using Label-Free Analysis with MaxQuant.
    Beer LA; Liu P; Ky B; Barnhart KT; Speicher DW
    Methods Mol Biol; 2017; 1619():339-352. PubMed ID: 28674895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
    Núñez Galindo A; Macron C; Cominetti O; Dayon L
    Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mining the acidic serum proteome utilizing off-gel isoelectric focusing and label free quantitative liquid chromatography mass spectrometry.
    Smith J; Davey G; Polom K; Roviello F; Bones J
    J Chromatogr A; 2018 Sep; 1566():32-43. PubMed ID: 29945787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Evaluation of the Use of Human Plasma and Serum for Mass-Spectrometry-Based Shotgun Proteomics.
    Lan J; Núñez Galindo A; Doecke J; Fowler C; Martins RN; Rainey-Smith SR; Cominetti O; Dayon L
    J Proteome Res; 2018 Apr; 17(4):1426-1435. PubMed ID: 29451788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed-mode ion exchange-based integrated proteomics technology for fast and deep plasma proteome profiling.
    Xue L; Lin L; Zhou W; Chen W; Tang J; Sun X; Huang P; Tian R
    J Chromatogr A; 2018 Aug; 1564():76-84. PubMed ID: 29935814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Biomarker Identification and Quantification by Microparticle Proteomics.
    Harel M; Geiger T
    Methods Mol Biol; 2017; 1619():477-486. PubMed ID: 28674905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cost-Effective High-Throughput Plasma and Serum Proteomics Workflow Enables Mapping of the Molecular Impact of Total Pancreatectomy with Islet Autotransplantation.
    Bennike TB; Bellin MD; Xuan Y; Stensballe A; Møller FT; Beilman GJ; Levy O; Cruz-Monserrate Z; Andersen V; Steen J; Conwell DL; Steen H
    J Proteome Res; 2018 May; 17(5):1983-1992. PubMed ID: 29641209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy and Reproducibility in Quantification of Plasma Protein Concentrations by Mass Spectrometry without the Use of Isotopic Standards.
    Kramer G; Woolerton Y; van Straalen JP; Vissers JP; Dekker N; Langridge JI; Beynon RJ; Speijer D; Sturk A; Aerts JM
    PLoS One; 2015; 10(10):e0140097. PubMed ID: 26474480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry.
    Keshishian H; Burgess MW; Specht H; Wallace L; Clauser KR; Gillette MA; Carr SA
    Nat Protoc; 2017 Aug; 12(8):1683-1701. PubMed ID: 28749931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma QconCATs reveal a gender-specific proteomic signature in apheresis platelet plasma supernatants.
    Dzieciatkowska M; D'Alessandro A; Hill RC; Hansen KC
    J Proteomics; 2015 Apr; 120():1-6. PubMed ID: 25743772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications.
    Qian WJ; Jacobs JM; Liu T; Camp DG; Smith RD
    Mol Cell Proteomics; 2006 Oct; 5(10):1727-44. PubMed ID: 16887931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-Scale and Deep Quantitative Proteome Profiling Using Isobaric Labeling Coupled with Two-Dimensional LC-MS/MS.
    Gritsenko MA; Xu Z; Liu T; Smith RD
    Methods Mol Biol; 2016; 1410():237-47. PubMed ID: 26867748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Throughput Plasma Proteomic Profiling.
    Soni RK
    Methods Mol Biol; 2022; 2546():411-420. PubMed ID: 36127608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mining the human plasma proteome with three-dimensional strategies by high-resolution Quadrupole Orbitrap Mass Spectrometry.
    Zhao Y; Chang C; Qin P; Cao Q; Tian F; Jiang J; Li X; Yu W; Zhu Y; He F; Ying W; Qian X
    Anal Chim Acta; 2016 Jan; 904():65-75. PubMed ID: 26724764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.